Publication list
2022
Papp, T.,
Winkler-Ferenczi, Z.,
Szilágyi, B.,
Petró, M.,
Varga, A.,
Kókai, É.,
Berényi, E.,
Oláh, G.,
Halmos, G.,
Szűcs, P.,
Mészár, Z.:
Ultrasound Used for Diagnostic Imaging Facilitates Dendritic Branching of Developing Neurons in the Mouse Cortex.
Front. Neurosci. 16 1-13, 2022.
Journal metrics:
Q2 Neuroscience (miscellaneous)
2021
Szabó, Z.,
Dezső, B.,
Molnár-Fodor, K.,
Szegedi, K.,
Flaskó, T.,
Szabó, E.,
Oláh, G.,
Sipos, É.,
Dobos, N.,
Gardi, J.,
Schally, A.,
Halmos, G.:
Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer.
Molecules. 26 (5), 1-14, 2021.
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
2020
Molnár-Fodor, K.,
Dobos, N.,
Schally, A.,
Steiber, Z.,
Oláh, G.,
Sipos, É.,
Székvölgyi, L.,
Halmos, G.:
The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma.
Oncotarget. 11 (2), 175-187, 2020.
2018
Sipos, É.,
Dobos, N.,
Rózsa, D.,
Molnár-Fodor, K.,
Oláh, G.,
Szabó, Z.,
Székvölgyi, L.,
Schally, A.,
Halmos, G.:
Characterization of Luteinizing hormone-releasing hormone (LH-RH-I) receptor type I as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.
OncoTargets Ther. 11 933-941, 2018.
Journal metrics:
Q2 Oncology
Q2 Pharmacology (medical)
Oláh, G.,
Dobos, N.,
Vámosi, G.,
Szabó, Z.,
Sipos, É.,
Molnár-Fodor, K.,
Harda, K.,
Schally, A.,
Halmos, G.:
Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
Eur. J. Pharm. Sci. 123 371-376, 2018.
Journal metrics:
Q1 Pharmaceutical Science
Harda, K.,
Szabó, Z.,
Szabó, E.,
Oláh, G.,
Molnár-Fodor, K.,
Szász, C.,
Méhes, G.,
Schally, A.,
Halmos, G.:
Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma.
Molecules. 23 (7), 1-13, 2018.
Journal metrics:
Q2 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
2017
Sipos, É.,
Dull, K.,
Treszl, A.,
Steiber, Z.,
Méhes, G.,
Dobos, N.,
Molnár-Fodor, K.,
Oláh, G.,
Székvölgyi, L.,
Schally, A.,
Halmos, G.:
Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
Oncol. Rep. 37 1927-1934, 2017.
Journal metrics:
Q3 Cancer Research
Q1 Medicine (miscellaneous)
Q2 Oncology
2013
Treszl, A.,
Steiber, Z.,
Schally, A.,
Block, N.,
Dezső, B.,
Oláh, G.,
Rózsa, B.,
Molnár-Fodor, K.,
Buglyó, A.,
Gardi, J.,
Berta, A.,
Halmos, G.:
Substantial expression of luteinizing hormone-releasing hormone (LHRH) receptor type I in human uveal melanoma.
Oncotarget. 4 (10), 1721-1728, 2013.
2012
2011
Steiber, Z.,
Treszl, A.,
Oláh, G.,
Buglyó, A.,
Rózsa, B.,
Berta, A.,
Halmos, G.:
Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Human Uveal Melanomas.
Invest. Ophthalmol. Vis. Sci. 52 6021, 2011.
updated: 2024-11-06, 14:04
